Ethnic and racial minority populations in the U.S. have a long history of being mistreated by the health care system, researchers and the government. The resulting mistrust can pose a challenge for researchers seeking to understand the biology of complex traits, as well as for physicians interested in delivering personalized care to diverse patients. Diversity in precision medicine research is crucial for understanding genetic differences that shape so many health outcomes and potential treatments.
Learn what physicians and health systems can do to advance precision medicine research and build rapport and trust to increase minority participation in critical research.
Genetics and precision medicine have become increasingly important in effective patient care. Through its partnerships and research, the AMA is advancing the ethical implementation of precision medicine.
About 10% of the worlds population is of European ancestry. However, this population accounts for 78% of genetic study participants. The National Institutes of Healths All of Us Research Program aims to address this disparity in medical research by enrolling 1 million or more participants to gather data on a wide variety of health conditions.
The AMA has partnered with the All of Us program, which aims to enable a new era of medicine through research, technology, and policies that empower patients, researchers and providers to work together to develop individualized care. This program is intended to gain better insights into the biological, environmental and behavioral influences on disease to enhance prevention and treatment.
The AMA Ed Hub module, All of Us Research Program: Informing the Future of Health Care, is enduring material and designated by the AMA for a maximum of 0.75 AMA PRA Category 1 Credit.
Learn more about AMA CME accreditation.
There are currently more than 320,000 All of Us participants, with about 250,000 having completed the initial steps of the program. Nationwide, more than 50% of All of Us participants are members of racial or ethnic minority groups. And in Illinois, more than 80% are from groups that have traditionally been underrepresented in biomedical research.
Joyce Ho, PhD, is a research assistant professor and lead investigator for the All of Us Research Program at Northwestern University Feinberg School of Medicine in Chicago. Ho shared how she and her colleagues in Illinois are engaging a diverse pool of participants, and offered advice for how physicians can help.
Were on track to build a sample of 1 million or more participants in the next five years or so, said Ho, adding that Illinois has more than 26,000 participants in the All of Us program to date. The Illinois Precision Medicine Consortium, which includes the University of Illinois, University of Chicago, Rush University Medical Center, NorthShore University Health System, and Cook County Health, is also in the lead nationally for how diverse their participant pool is.
The effort thats needed to reach diverse populations is something that we were prepared to put in, she said. We understood just from the history of research in this countryespecially with underrepresented populationsthat its not just, Hey, heres a consent form, please read it and we know you will participate.
Instead, trust must be built through providing honest and accurate answers to patients questions about precision medicine, the privacy and security of patients data, and more.
Those are all concepts that, regardless of how much you know about biomedical research, or whether you have participated in studies, you deserve a thorough explanation, said Ho.
Learn how to answer patients top five questions about the All of Us Research Program.
The actions of past medical researchers have earned much distrust in minority communities, making it crucial to treat these diverse populations as partners.
Nationally, even at the beginning of designing the All of Us Research Programbecause we know that we have this goal of building a diverse research databasewe made sure that participants are our partners, said Ho.
Participants from all walks of life should be included and valued in the design of the program. Everyone plays a major role.
The National Institutes of Health and its All of Us Research Program partners conducted focus groups to look at everything from participating in research to concepts about precision medicine and sharing data, said Ho. Theres a lot of work ... that we put in to understand how we can really build this resource in a way that includes what different communities want so that we really can benefit the health of people who are living in this country.
One of the most important ways that All of Us Research Program researchers in Illinois have approached this program is in the collaboration of community organizations, health systems and participants. All of Us Research Program investigators in Illinois have decades of experience working with diverse communities in biomedical research.
Transportation is often a barrier to working with underrepresented communities. It can prevent patients from receiving the health care they need. In Illinois, though, mobile clinical research units have allowed researchers to better reach these communities.
Researchers drive these research vehicles containing exam rooms to different communities to engage people about the program. They also leverage long-standing relationships with area churches, community organizations and clinics to engage community members.
That breaks down a lot of the barriers with transportation that happens in many of the communities here in Chicago, said Ho. It really makes a big difference in terms of being able to reach this community.
Engagement is keyin creating a diverse community of participants for precision medicine and biomedical research.
When we go out to talk to folks, we dont immediately ask people to participate. A lot of times, we just have great conversations with people about biomedical research, said Ho. A lot of times we are addressing a potential mistrust that has very reasonably existed in different communities.
For example, the University of Chicago has developed curriculum aimed at addressing mistrust, biomedical research and importance of research inclusion, especially among the African American community.
Our teams develop different engagement tools and strategies to reach communities that have been underrepresented in research, she said, adding that it goes beyond talking to someone for five or 10 minutes before they participate.
Instead, it is multiple conversations over time, and letting participants know that we aim to return health information back to them and perhaps in the future, they might decide to participate, said Ho.
And once participants have shared their information, it is important to reiterate that there will be a waiting period.
One of the challenges is to really explain to participants this is a long-term program and it really takes a lot of time and patience for us to be able to return the value back to you that you deserve, she said.
One of the missions of the program is not just building 1 million people and collecting all this data. Its just to have substantive conversations with people about the importance of inclusion in biomedical research to build awareness, she said.
By creating awareness around precision medicine and building trust within these communities, it is paving the way for future conversations.
Even if theyre being approached by another research group, theyll have a little more trust and understanding about why participation and representation is so important, said Ho.
Illinois All of Us researchers also have a community participant advisory board that provides feedback on the program. Together they discuss additional ways to engage Illinois communities.
These meetings cover items such as how to provide clinically relevant information to participants, which is one of the hallmarks of the program, Ho said. Were not just grabbing the data. Were also planning to return information back to participants.
Not only does the program have a 1-million-person database to build, but they need to have an infrastructure that is ready to process the volume of data and biosamples, while also prioritizing data security and privacy.
Our program spends a lot of resources building as secure of a data system as possible, said Ho, adding that there is also a whole pipeline of generating genomic data and clinically relevant data to return to participants.
Many people are wondering about the security and privacy of the data, so we need to not just build a very secure system, but be able to explain to people what the risks might be so that people can make an informed decision, she said.
One way that the All of Us program is building a robust research resource, is to include EHR data from participants. However, it is important for participants and physicians to know that the data is securely sharedall personal identifiable information is removed.
Data collected will be connected to other data types such as self-reported information, which includes health background and behaviors, as well as medical history, physical measurements and data gleaned from biosamples.
Theres a wide variety of longitudinal data were collecting from participants. Through a research data portal that the program is building, researchers will eventually be able to access data and samples to accelerate medical discoveries for diverse populations. Thats powerful, said Ho.
View post:
7 ways to expand diversity in precision medicine research - American Medical Association
- Clemson professor Trudy Mackay elected to the National Academy of Medicine - Clemson News - October 22nd, 2024
- Research sheds new light on the behavior of KRAS gene in pancreatic and colorectal cancer - News-Medical.Net - October 22nd, 2024
- Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon - Nature.com - October 22nd, 2024
- Tailored Genetic Medicine: AAV Gene Therapy and mRNA Vaccines Redefine Healthcare's Future - Intelligent Living - October 22nd, 2024
- The Genetic Link to Parkinson's Disease - Hopkins Medicine - August 27th, 2022
- Epic Bio makes gene therapies by editing the epigenome - Labiotech.eu - August 27th, 2022
- Ovid turns to gene therapy startup to restock drug pipeline - BioPharma Dive - August 27th, 2022
- Whole-exome analysis of 177 pediatric patients with undiagnosed diseases | Scientific Reports - Nature.com - August 27th, 2022
- First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN (valoctocogene roxaparvovec), Approved by European Commission (EC) -... - August 27th, 2022
- Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases - BioSpace - August 27th, 2022
- ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines - Business Wire - August 27th, 2022
- ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene... - August 27th, 2022
- Genetic variants cause different reactions to psychedelic therapy - The Well : The Well - The Well - August 27th, 2022
- Personalized Medicine for Prostate Cancer: What It Is and How It Works - Healthline - August 27th, 2022
- Four radical new fertility treatments just a few years away from clinics - The Guardian - August 27th, 2022
- Why are Rats Used in Medical Research? - MedicalResearch.com - August 27th, 2022
- The Columns Stepping Stones in STEM Washington and Lee University - The Columns - August 27th, 2022
- Study points to new approach to clearing toxic waste from brain Washington University School of Medicine in St. Louis - Washington University School... - August 27th, 2022
- ALS Gene Therapy SynCav1 Found to Extend Survival in Mouse Model |... - ALS News Today - August 27th, 2022
- A New Kind of Chemo | The UCSB Current - The UCSB Current - August 27th, 2022
- Unraveling the mystery of who gets lung cancer and why - Genetic Literacy Project - June 16th, 2022
- How diet and the microbiome affect colorectal cancer - EurekAlert - June 16th, 2022
- Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear... - May 20th, 2022
- Money on the Move: SwanBio, Remix, Locus, Mirvie and More - BioSpace - May 20th, 2022
- DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Companies Bringing New Treatments to Patients - PR Newswire - May 20th, 2022
- Brain tumor growth may be halted with breast cancer drug - Medical News Today - May 20th, 2022
- LogicBio Therapeutics to Present at HC Wainwright Global Investment Conference - PR Newswire - May 20th, 2022
- Genascence Announces Data From Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, Presented at American Society of Gene... - May 20th, 2022
- Encoded Therapeutics Presents Nonclinical Data Showing Genomic Medicine Platform Yields Selective Expression to Optimize Gene Therapy Performance at... - May 20th, 2022
- California, Other States to Cover Rapid WGS of Newborns Under Medicaid, but Questions of Access Loom - GenomeWeb - May 20th, 2022
- Researchers Identify Role of 'Sonic the Hedgehog' Gene in Bone Repair - BioSpace - May 20th, 2022
- Targeting the Uneven Burden of Kidney Disease on Black Americans - The New York Times - May 20th, 2022
- ASC Therapeutics, U Mass Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine... - May 20th, 2022
- UC Davis Looks to Expand Genetic Breast Cancer Risk Education, Outreach for Hispanic Women - Precision Oncology News - May 20th, 2022
- Fly Researchers Find Another Layer to the Code of Life - Duke Today - May 20th, 2022
- CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Business... - May 20th, 2022
- Omicron BA.4 and BA.5: What to know about the new variants - Medical News Today - May 20th, 2022
- Krystal Biotech to Present Additional Data on B-VEC from the GEM-3 Phase 3 Study at the Society for Investigative Dermatology Annual Meeting -... - May 20th, 2022
- FDA approves Lilly's Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2... - May 20th, 2022
- Elucidating the developmental origin of life-sustaining adrenal glands | Penn Today - Penn Today - May 20th, 2022
- 5 questions facing gene therapy in 2022 - BioPharma Dive - January 17th, 2022
- In a First, Man Receives a Heart From a Genetically Altered Pig - The New York Times - January 17th, 2022
- Antibodies, Easy Single-Cell, Genomics for All: Notes from the JP Morgan Healthcare Conference - Bio-IT World - January 17th, 2022
- Using genetics to conserve wildlife - Pursuit - January 17th, 2022
- Genetics of sudden unexplained death in children - National Institutes of Health - January 17th, 2022
- Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance - Yahoo Finance - January 17th, 2022
- Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically... - January 17th, 2022
- How The mRNA Vaccines Were Made: Halting Progress and Happy Accidents - The New York Times - January 17th, 2022
- Press Registration Is Now Open for the 2022 ACMG Annual Clinical Genetics Meeting - PRNewswire - January 17th, 2022
- A Novel Mutation in the TRPM4 Gene | RRCC - Dove Medical Press - January 17th, 2022
- Biomarkers and Candidate Therapeutic Drugs in Heart Failure | IJGM - Dove Medical Press - January 17th, 2022
- Genetic counseling program helps patients take control of their health - Medical University of South Carolina - June 24th, 2021
- One-year-old baby in UAE receives imported genetic medicine to treat rare disease - Gulf News - June 24th, 2021
- Black and non-Hispanic White Women Found to Have No Differences in Genetic Risk for Breast Cancer - Cancer Network - June 24th, 2021
- What's in your genes | The Crusader Newspaper Group - The Chicago Cusader - June 24th, 2021
- Immusoft Announces Formation of Scientific Advisory Board - Business Wire - June 24th, 2021
- Arrowhead Presents Positive Interim Clinical Data on ARO-HSD Treatment in Patients with Suspected NASH at EASL International Liver Congress - Business... - June 24th, 2021
- Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole - GlobeNewswire - June 24th, 2021
- Despite the challenges of COVID-19, Yale-PCCSM section members continued their work on scientific papers - Yale School of Medicine - June 24th, 2021
- Veritas Intercontinental: Genetics makes it possible to identify cardiovascular genetic risk and prevent cardiac accidents such as those that have... - June 24th, 2021
- New Research Uncovers How Cancers with Common Gene Mutation Develop Resistance to Targeted Drugs - Newswise - June 24th, 2021
- Celebrate the Third Annual Medical Genetics Awareness Week April 13-16, 2021 - PRNewswire - February 14th, 2021
- How will WNY fare in the race between vaccines and coronavirus variants? - Buffalo News - February 14th, 2021
- Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences - GlobeNewswire - February 14th, 2021
- ASCO GU 2021: The Landscape of Genetic Alterations Using ctDNA-based Comprehensive Genomic Profiling in Pat... - UroToday - February 14th, 2021
- The Human Genome and the Making of a Skeptical Biologist - Scientific American - February 14th, 2021
- Breast Cancer Gene Mutations Found in 30% of All Women - Medscape - February 1st, 2021
- Mysterious untreatable fevers once devastated whole families. This doctor discovered what caused them - CNN - February 1st, 2021
- CCMB team identifies variants of genes that metabolise drugs - BusinessLine - February 1st, 2021
- NeuBase Therapeutics Announces Acquisition of Gene Modulating Technology from Vera Therapeutics - GlobeNewswire - February 1st, 2021
- Copy number variations linked to autism have diverse but overlapping effects - Spectrum - February 1st, 2021
- Genomes, Maps, And How They Affect You - IFLScience - February 1st, 2021
- SMART Study Finds 22q11.2 Microdeletion Prevalence Much Higher than Expected - PRNewswire - February 1st, 2021
- Are Phages Overlooked Mediators of Health and Disease? - The Scientist - February 1st, 2021
- When Your Chance for a Covid Shot Comes, Dont Worry About the Numbers - Kaiser Health News - February 1st, 2021
- Global CRISPR Gene Editing Market: Focus on Products, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and... - February 1st, 2021
- The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene MutationExtraordinary Results With Sotorasib - SurvivorNet - February 1st, 2021
- Genetic Testing: MedlinePlus - January 29th, 2021
- 21 Common Genetic Disorders: Types, Symptoms, Causes ... - January 29th, 2021
- Genetic Counseling Online Course - School of Medicine ... - January 29th, 2021